Search results
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: Biogen has seen “encouraging early trends” in the launch of its postpartum depression...
Postpartum low-dose esketamine aids moms with prenatal depression
Medical Xpress· 5 days agoA single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum...
Teen stress may boost risk of postpartum depression later
Futurity· 6 days agoThe researchers say this corresponds to the equivalent hormonal changes in postpartum women exposed...
Is Natural Hormone Replacement Therapy Better?
Verywell Health via Yahoo News· 2 hours agoHowever, your body cannot convert the diosgenin in wild yam into progesterone; this can only be done in a lab. All supplements carry a risk of side...
Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
Benzinga via Yahoo Finance· 1 day agoThe company reported sales of $2.29 billion, down 7% year over year and missing the consensus of...
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations
Investor's Business Daily· 1 day agoThere are now more than 1,100 patients in the U.S. on the drug, RBC's Abrahams said. That's 24% of...
Biogen to invest more in launch of Alzheimer’s drug Leqembi
BioPharma Dive via Yahoo Finance· 1 day agoEven though Biogen and Wall Street had high hopes for Leqembi, getting the drug to patients has...
Hayden Panettiere Is Making Moves in Her Hollywood Comeback With This Major Project
SheKnows via Yahoo News· 6 days agoHayden Panettiere is making her way back to Hollywood with a comeback that will probably open new...
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 1 day agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...
Biogen Beats Estimates as Alzheimer’s Drug Gains Traction
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Biogen Inc. reported first-quarter profit that beat Wall Street’s expectations as the...
